Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05509049 · ClinicalTrials.gov registry record · NA
Precision Nudging Drives Wellness Visit Attendance at Scale
A NA study, sponsored by Lirio.
- Completed
- Registry status
- NA
- Development phase
- 30,068
- Enrollment target
NCT05509049: Completed NA study, sponsored by Lirio.
NCT05509049 is a NA study that has completed, run by Lirio. The registered enrollment target is 30,068 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2043% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05509049, a NA study, has completed, sponsored by Lirio.
- COMPLETED
- Registry status
- NA
- Development phase
- 30,068 participants
- Enrollment target
Study Summary
The purpose of the present randomized controlled trial is to explore the effectiveness of a 12-month well woman digital health intervention leveraging Precision Nudging - the application of behavioral science and reinforcement learning to create individualized, tailored health messaging at scale that matches the right message to the right person at the right time - in promoting behavior change. Specifically, it is hypothesized that scaling behavioral science through reinforcement learning will be more effective at motivating participants to engage with well woman messages and to schedule and to attend a well woman visit compared to a standard of care message.
Interventions
- OTHER Standard of care
- OTHER Precision nudging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,068 participants |
| Start Date | 2022-09-07 |
| Est. Completion | 2024-01-09 |
| Phase | NA |
What the finished NCT05509049 record still lists
NCT05509049 is an interventional study that assigns participants to a tested intervention. Its 30,068 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2043% higher).
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT05509049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05509049 about?
NCT05509049 is a clinical study titled "Precision Nudging Drives Wellness Visit Attendance at Scale". The purpose of the present randomized controlled trial is to explore the effectiveness of a 12-month well woman digital health intervention leveraging Precision Nudging - the application of behavioral science and reinforcement learning to create individualized, tailored health messaging at scale tha...
What is the current status of trial NCT05509049?
This trial is currently completed. It is a NA study. The enrollment target is 30,068 participants. The study started on 2022-09-07. Estimated completion is 2024-01-09.
What interventions are being tested in trial NCT05509049?
The interventions under investigation include: Standard of care (OTHER), Precision nudging (OTHER).
Who is sponsoring clinical trial NCT05509049?
This trial is sponsored by Lirio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05509049's enrollment target sits among peer trials
30,068 8th of 2000 higher than 1,993 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI